Scientists search for clues in genes to personalize PKU treatment
NCT ID NCT07255599
Summary
This study aims to understand how patients with Phenylketonuria (PKU) respond to a supplement called tetrahydrobiopterin (BH4). Researchers will give BH4 to 20 patients and measure changes in a key blood chemical. They will also check if a patient's genetic makeup can predict how well they will respond to this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA (PKU) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sohag Faculty of Medicine
Sohag, Egypt
Conditions
Explore the condition pages connected to this study.